Doçent Doktor SUNA YAPALI

Eğitim

• 2017 İleri Endoskopi ve Motilite, Academic Medical Center, Amsterdam Hollanda
• 2014 University of Michigan, Division of Gastroenterology and Hepatology, Ann Arbor, MI, ABD / Hepatology Research Fellowship
• 2012 Ege Üniversitesi Tıp Fakültesi Gastroenteroloji
• 2008 Marmara Üniversitesi Tıp Fakültesi İç Hastalıkları
• 2001 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi

İş Deneyimi

• 2012 - 2014 University of Michigan, Division of Gastroenterology and Hepatology, Ann Arbor, MI, ABD
• 2009 - 2012 Ege Üniversitesi Tıp Fakültesi Gastroenteroloji Anabilim Dalı
• 2008 - 2009 Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, Gastroenteroloji Bölümü
• 2008 Acıbadem Sağlık Grubu
• 2002 - 2008 Marmara Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı

Üyelikler

• American Gastroenterology Association
• American Association for the Study of Liver Disease
• European Association for the Study of Liver Disease
• Türk Karaciğer Araştırmaları Derneği
• Türk Gastroenteroloji Derneği
• Ulusal İnflamatuvar Barsak Hastalıkları Derneği

BİLİMSEL YAYINLAR

• Management of Hepatitis B: My Practice and How it Relates to the Guidelines. Clin Gastroenterol Hepatol 2014;12(1):16-26. Yapali S, Talaat N, Lok AS.
• Outcome of chronic hepatitis B patients who do not meet criteria for antiviral treatment at presentation. Clin Gastroenterol Hepatol 2014 Jul 17. pii: S1542- 3565(14)01048-9. doi: 10.1016/j.cgh.2014.07.019. Yapali S, Talaat N, Fontana RJ, Oberhelman K, Lok AS.
• The potential benefit of telbivudine does not outweigh its high rate of antiviral drug resistance and other adverse effects. Gastroenterology 2014;146(1)15-9. Yapali S, Lok AS.
• Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV? Gut 2014, Apr 1. doi: 10.1136/gutjnl-2014-306935. Yapali S, Lok AS.
• Should this patient be treated? Best practices in identifying cirrhosis and HCC in patients infected with HBV ? Role of prediction models. Johns Hopkins Medicine eViralHepatitis Review 2012, Volume 3, Issue 3. Yapali S, Lok AS.
• Giant esophageal lipoma presenting with gastroesophageal reflux symptoms. J Gastrointestinal Liver Diseases 2013;22(1):8. Yapali S, Oruc N, Harman M, Aydin A.
• A severe case of esophageal ulcer causing a tight stricture despite long-term D-penicillamine treatment. Wiener Klin Wochenschr 2014 Yapali S, Turan I, Ozutemiz O, Tekesin O.
• Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease. UEG Journal 2014 DOI: 10.1177/2050640614550851 Bor S, Valytova E, Yapali S, Yildirim E, Vardar R.
• "Predictors of histologic progression and clinical outcomes for patients with chronic hepatitis C: A systematic review" Aliment Pharmacol Ther 2014;40(8):863-79. doi: 10.1111/apt.12921. Konerman M, Yapali S, Lok AS.
• Changes in the characteristics of Hepatitis C patients seen in a liver center in the United States during the last decade. J of Viral Hepat 2014 2014 Oct 14. doi: 10.1111/jvh.12343. Talat N, Yapali S, Fontana RJ, Conjeevaram H, Lok AS.

.
.
.
Daha Fazla Göster